T. OH‐ISHI
T. OH‐ISHI publishes mostly in Organic Chemistry, Molecular Biology and Spectroscopy, on topics such as Synthesis and bioactivity of alkaloids, Asymmetric Synthesis and Catalysis and Chemical Synthesis and Analysis.
- World rank
- #7,597,018 of 7,710,434 ranked researchers
- Rank in United States
- #1,619,057 of 1,627,098
- Works
- 47
- Citations
- 285
- Citations per work
- 6.1
What does T. OH‐ISHI research?
T. OH‐ISHI's work is mostly in Chemistry (60%), Biochemistry, Genetics and Molecular Biology (19%), Medicine (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2860.3%
- Chemistry2860.3%
- Life Sciences1021.4%
- Everything else715.2%
- Health Sciences13.1%
- Medicine13.1%
- 1Organic Chemistry52% of their works
- 2Molecular Biology19% of their works
- 3Spectroscopy5% of their works
- 4Inorganic Chemistry4% of their works
- 5Pharmacology3% of their works
- 6Pharmaceutical Science2% of their works
Research topics
- Synthesis and bioactivity of alkaloids
- Asymmetric Synthesis and Catalysis
- Chemical Synthesis and Analysis
- Synthesis and Biological Evaluation
- Synthesis and pharmacology of benzodiazepine derivatives
- Chemical synthesis and alkaloids
- Synthesis and Characterization of Heterocyclic Compounds
- Multicomponent Synthesis of Heterocycles
Which keywords describe T. OH‐ISHI's research?
The keywords of their largest research topics: Synthesis, Anticancer Agents, Asymmetric Synthesis, Biological Evaluation, Cytotoxicity, Drug Discovery, Beta-Carboline Alkaloids and Pharmacological Functions.
- Multicomponent Reactions
- Antimicrobial
- Alkaloids
- DNA-Interactive Agents
- Peptide Synthesis
- Antimicrobial Activity
- Enantioselective Reactions
- Pharmacological Functions
- Drug Discovery
- Biological Evaluation
- Anticancer Agents
- Synthesis
- Asymmetric Synthesis
- Cytotoxicity
- Beta-Carboline Alkaloids
- Anticancer
- Organocatalysis
- Foldamers
- Quinoxaline
- Pyrrolobenzodiazepines
- Amaryllidaceae
- Green Chemistry
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Synthesis305 topics
- Anticancer Agents172 topics
- Asymmetric Synthesis173 topics
- Biological Evaluation163 topics
- Cytotoxicity152 topics
- Drug Discovery153 topics
- Beta-Carboline Alkaloids101 topic
- Pharmacological Functions101 topic
- Anticancer82 topics
- Enantioselective Reactions81 topic
- Organocatalysis81 topic
- Antimicrobial Activity71 topic
- Foldamers71 topic
- Peptide Synthesis71 topic
- Quinoxaline71 topic
- DNA-Interactive Agents51 topic
- Pyrrolobenzodiazepines51 topic
- Alkaloids41 topic
- Amaryllidaceae41 topic
- Antimicrobial41 topic
- Green Chemistry41 topic
- Multicomponent Reactions41 topic
- Triazines41 topic
Where does T. OH‐ISHI work?
T. OH‐ISHI's main affiliation in the publication record is Tanabe Research Laboratories, United States.
How many publications and citations does T. OH‐ISHI have?
OpenAlex counts 47 works and 285 citations for T. OH‐ISHI, an h-index of 10, ranking #7,597,018 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about T. OH‐ISHI. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.